NorthSea Therapeutics
ID: 17658696Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.
4
Funding Rounds
$136.4m
Money raised
Recent Funding Rounds
Overview
Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.
- Website:
- Business model: B2B
- Headquarters: Amsterdam
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company NorthSea Therapeutics has raised a total of $136.4m in funding over 4 rounds.
Key Insights:
- NorthSea Therapeutics Series B round, January 2020: $40m
- NorthSea Therapeutics January 2020 Series B Funding Round: $40m
- NorthSea Therapeutics Series A round, December 2017: $29.4m
- NorthSea Therapeutics December 2017 Series A Funding Round: $27m
Industries
NorthSea Therapeutics is active in the following industries: